Project Grant HT94252410149
Award Date 3/1/24
Completion Date 2/28/26
Dollars Obligated $240K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Germany
Similar Awards
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $148,942 to the Westfaelische Wilhelms-Universitaet Muenster in Germany to conduct research on identifying and characterizing the guanine nucleotide exchange factor (GEF) for the small GTPase Rheb as a novel target for treating tuberous sclerosis complex (TSC). The two-year award, running from July 1, 2024 to June 30, 2026, will support the university's...
- This federal Project Grant award of $219,568.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Universitat Bern to investigate the role of intestinal secreted microRNAs in regulating the gut microflora and their impact on inflammatory bowel disease. The research aims to improve understanding of the underlying mechanisms of this condition, which is of relevance to military health. The award has a performance...
- This federal Project Grant award of $400,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, with a performance period from October 1, 2024 to September 30, 2026. The award supports research by the University of Maryland, Baltimore to develop "drug conjugates of modified LGR4/5/6 ligands for cancer treatment." The university, as the prime awardee, has extensive expertise in biomedical research, clinical trials, and...
- The U.S. Defense Health Agency awarded a $989,167 Project Grant to the University of Bern in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant, effective from February 15, 2024 to February 14, 2027, supports research to define the role of the SWI/SNF chromatin remodeling complex in advanced metastatic castration-resistant prostate cancer (mCRPC) therapy resistance. Through this grant, the University of Bern will conduct basic, translational, and...
- This federal Project Grant award, valued at $548,133.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Basel in Switzerland focused on "Neuronal Regulation of Antitumor Immunity". The award, which began on September 15, 2024 and is scheduled for completion by September 14, 2027, aims to conduct advanced biomedical research investigating the role of neuronal processes in...
- The Defense Health Agency awarded a $462,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Albert Einstein College of Medicine in Bronx, NY. This grant, with a period of performance from January 1, 2025 to December 31, 2026, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on the "Proteomics of Vascular Wall...
- The U.S. Defense Health Agency awarded a $241,500 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "UNDERSTANDING THE MOLECULAR COMMUNICATION BETWEEN PROSTATE CANCER CELL TYPES." The two-year grant, with a performance period from September 1, 2025 to August 31, 2027, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- This $377,932 federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Louisiana State University Health Sciences Center New Orleans to develop innovative techniques for dispersing bacterial biofilms on bones and medical hardware. The research aims to improve the treatment of bone fractures and infections, with a focus on advancing enzymatic debridement approaches. The award period runs from...
- The Defense Health Agency has awarded a $1,581,751 Project Grant to Duke University to conduct the "THERAPEUTIC INTERVENTION TO REVERSE GASTRIC PRECANCER" research project under the Military Medical Research and Development program (CFDA 12.420). This federal grant, with a performance period from June 1, 2024 to May 31, 2028, will enable Duke University's researchers to investigate innovative therapeutic interventions to reverse precancerous gastric conditions. The Military Medical...